We may all need a CART someday?

Experts Tout CARTs To Treat ALL.

A 3,500-word story titled “Is This How We’ll Cure Cancer?” that will be published in the May 26 issue of Forbes (5/8, Herper, 6.28M) reports on the use of chimeric antigen receptor T-cells (CARTs) to treat ALL. Clifford Hudis, president of the American Society of Clinical Oncology, said, “So far, it’s only blood cancer, it’s high technology, it’s customized therapy, it’s going to require major investment.” According to Forbes, Hudis “is nonetheless excited about the cells.” Crystal Mackall, “who is developing similar treatments at the National Cancer Institute, “ said, “It really is a revolution. This is going to open the door for all sorts of cell-based and gene therapy for all kinds of disease because it’s going to demonstrate that it’s economically viable.”